Expansion of HIV/AIDS, STI and TB Laboratory Activities in the Namibia Institute of Pathology (NIP), Ltd. under the President’s Emergency Plan for AIDS Relief

Post Date

March 31st 2009

Application Due Date

May 28th 2009

Applications are due by 5:00pm Eastern time on closing date

Funding Opportunity Number

CDC-RFA-PS09-955

CFDA Number(s)

93.067

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

1

Eligibility Categories

Other

Namibia Institute of Pathology (NIP)

Funding

• Estimated Total Funding:

  $12500000

• Award Range:

  $1000000 - $2144093

Grant Description

CDC’s Procurement and Grants Office has published a program announcement entitled, “Expansion of HIV/AIDS, STI and TB Laboratory Activities in the Namibia Institute of Pathology (NIP), Ltd. under the President’s Emergency Plan for AIDS Relief.” Approximately $2,144,093 will be available to fund approximately one award. The purpose of the program is to improve national surveillance for HIV infection, sexually transmitted infections (STIs), and tuberculosis (TB), as well as to expand the capacity of the Namibia Institute of Pathology (NIP) to provide services for diagnosing and managing these diseases and others related to HIV infection and transmission in Namibia. For complete program details, please see the full announcement. The estimated funding date is prior to September 30, 2009.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  PGO TIMS
  Phone 770-488-2700

• Agency Mailing Address:

  General Email

• Agency Email Address:

  pgotim@cdc.gov